Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar.
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2013
At a glance
- Drugs Sorafenib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms PREDICT
- Sponsors Bayer
- 19 Oct 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004113).
- 13 Sep 2011 Final results will be presented at ECCO-ESMO 2011, according to a Bayer press release.
- 29 Sep 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.